S
Sentynl Therapeutics, Inc.
0 followers
Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.
Org chart
Matt Heck
Collapse
Darren Pincus
Senior Vice President, Business Development
Grant Castor
Senior Vice President Commercial Strategy & Operations
Michael Hercz
Senior Vice President, General Counsel & Chief Compliance Officer
Jennifer Reese
Senior Vice President & Head Of Medical Affairs
Mike Cvijanovich
Senior Director Of Rare Disease Marketing
Yvonne Breugelmans Mshrm
Director Of Human Resources And Payroll